-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: October 2012
#BIF2012 Company Snapshot: Profil Institute for Translational Medicine
For the next Company Snapshot for the BIO Investor Forum, we’ve spoken with one of the presenting companies at the event, Profil Institute for Translational Medicine, Inc. To find out more about this organization and what they’re doing for biotech, please read below! You’ll be able to see their presentation onsite, Wednesday 10/10 at 9:30am in the Presidio Room. Company Snapshot What is your company’s lead product or technology? Based on collaborations with biopharma, Read More >
BIO’s Pacific Rim Summit to Focus on Building the Biobased Economy
BIO’s 2012 Pacific Rim Summit on Industrial Biotechnology and Bioenergy comes to Vancouver, Canada next week, October 9-12. Now in its 7th year, the Summit will explore the latest issues in industrial biotechnology, including algae, advanced biofuels, biopolymers and bioplastics, dedicated energy crops, green chemistry, and synthetic biology. “We are excited to bring this conference to Vancouver to highlight the industry’s growth, particularly in Canada,” said Brent Erickson, executive vice president for BIO’s Industrial & Environmental Read More >
2012 BIO Technology Transfer Symposium
BIO’s Technology Transfer Symposium is right around the corner, next Monday, October 8th in fact. And whether you are planning on attending the BIO Investor Forum, the Tech Transfer offers a unique insight in to the value of biotech public-private partnerships. The Tech Transfer highlights recent and successful early stage technology transfer deals from a variety of perspectives, including universities, government and venture capitalists. Attendees will learn about how technology transfer offices and industry are working Read More >
Southern California Biotech Magnet School will Prepare Next Gen Workforce
Despite increasing global competition, the United States remains the most innovative country on the planet. This competition, of course, is good because it means education and research are growing in the rest of the world. There is some debate as to whether or not this nation is facing a potential hi-tech labor shortage. Though, one thing is certain – teaching science, math, and technology to all kids is so important. This is not just because Read More >
Virginia Bio Announces New Executive Leadership
The Virginia Biotechnology Association (Virginia Bio), the premier statewide non-profit trade association for life science industries, has named its interim executive director to the full-time position of chief executive officer. With an extensive background in the law and non-profit sectors as well as the life sciences, Jeffrey Gallagher brings leadership and policy expertise to his newly defined role, where he will be responsible for developing and executing the association’s strategic plans, prioritizing the organization’s areas Read More >
